Latest Keytruda Study Shows Limited Results for Most Mesothelioma Patients
|

Latest Keytruda Study Shows Limited Results for Most Mesothelioma Patients

Results of the latest Keytruda study show the drug works well for a select few mesothelioma patients, but not well at all for most others. Keytruda is the brand name for pembrolizumab. It is a type of immunotherapy drug. Early studies suggested that Keytuda might offer real hope for people with the aggressive cancer, malignant pleural mesothelioma.  But the latest Keytruda study shows most patients do not have lasting results with this treatment. That is especially true for patients whose cells do not express high levels of the protein PD-1. How the Latest Keytruda Study Worked Keytruda is an immunotherapy drug. It works by activating the immune system. Mesothelioma cells can use a protein called PD-1 to protect themselves from…